IGC Pharma, Inc. (IGC)
0.2797
0.00 (0.00%)
USD |
NYAM |
Oct 08, 16:00
0.2797
0.00 (0.00%)
After-Hours: 16:19
IGC Pharma Net Income (Quarterly) : -2.936M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.936M |
| March 31, 2026 | -2.402M |
| December 31, 2025 | -0.726M |
| September 30, 2025 | -1.821M |
| June 30, 2025 | -1.599M |
| March 31, 2025 | -1.382M |
| December 31, 2024 | |
| September 30, 2024 | -1.717M |
| June 30, 2024 | -2.378M |
| March 31, 2024 | -2.885M |
| December 31, 2023 | -5.589M |
| September 30, 2023 | -2.451M |
| June 30, 2023 | -2.075M |
| March 31, 2023 | -4.03M |
| December 31, 2022 | -2.249M |
| September 30, 2022 | -2.442M |
| June 30, 2022 | -2.785M |
| March 31, 2022 | -6.503M |
| December 31, 2021 | -2.381M |
| September 30, 2021 | -4.344M |
| June 30, 2021 | -1.788M |
| March 31, 2021 | -2.949M |
| December 31, 2020 | -2.323M |
| September 30, 2020 | -1.657M |
| June 30, 2020 | -1.882M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.154M |
| December 31, 2019 | -1.603M |
| September 30, 2019 | -1.179M |
| June 30, 2019 | -1.379M |
| March 31, 2019 | -1.578M |
| December 31, 2018 | -1.148M |
| September 30, 2018 | -0.858M |
| June 30, 2018 | -0.5123M |
| March 31, 2018 | -0.5746M |
| December 31, 2017 | -0.533M |
| September 30, 2017 | -0.3039M |
| June 30, 2017 | -0.4325M |
| March 31, 2017 | -0.7699M |
| December 31, 2016 | -0.073M |
| September 30, 2016 | -0.5889M |
| June 30, 2016 | -0.3603M |
| March 31, 2016 | -1.395M |
| December 31, 2015 | -0.4448M |
| September 30, 2015 | -0.6404M |
| June 30, 2015 | -0.3536M |
| March 31, 2015 | -1.959M |
| December 31, 2014 | -0.599M |
| September 30, 2014 | -0.9159M |
| June 30, 2014 | -1.210M |
| March 31, 2014 | -1.490M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | 169.40M |
| Fulcrum Therapeutics, Inc. | -26.18M |
| Definium Therapeutics, Inc. | -158.99M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.265M |
| Total Expenses (Quarterly) | 3.201M |
| EPS Diluted (Quarterly) | -0.0293 |
| Enterprise Value | 29.40M |
| Gross Profit Margin (Quarterly) | 2.64% |
| Profit Margin (Quarterly) | -1.11K% |
| Earnings Yield | -29.17% |
| Normalized Earnings Yield | -29.17 |